Εμφανίζονται 1 - 20 Αποτελέσματα από 23 για την αναζήτηση '"РЕЗЕКЦИЯ КИШЕЧНИКА"', χρόνος αναζήτησης: 0,66δλ Περιορισμός αποτελεσμάτων
  1. 1
  2. 2
  3. 3
    Academic Journal

    Πηγή: Сборник статей

    Περιγραφή αρχείου: application/pdf

    Relation: Актуальные вопросы современной медицинской науки и здравоохранения: сборник статей VIII Международной научно-практической конференции молодых учёных и студентов, Екатеринбург, 19-20 апреля 2023 г.; http://elib.usma.ru/handle/usma/14494

    Διαθεσιμότητα: http://elib.usma.ru/handle/usma/14494

  4. 4
  5. 5
    Academic Journal

    Πηγή: Clinical and experimental pathology; Vol. 20 No. 4 (2021) ; Клиническая и экспериментальная патология; Том 20 № 4 (2021) ; Клінічна та експериментальна патологія; Том 20 № 4 (2021) ; 2521-1153 ; 1727-4338

    Περιγραφή αρχείου: application/pdf

  6. 6
  7. 7
  8. 8
  9. 9
    Academic Journal
  10. 10
    Academic Journal

    Πηγή: Surgery and Oncology; Том 9, № 4 (2019); 32-36 ; Хирургия и онкология; Том 9, № 4 (2019); 32-36 ; 2949-5857

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.onco-surgery.info/jour/article/view/350/295; ESGO Ovarian Cancer Surgery Guidelines. European Society of Gynaecological Oncology, 2017. V. 2. Available at: http:// guidelines.esgo.org.; Chi D.S., Eisenhauer E.L., Zivanovic O. et al. Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. Gynecol Oncol 2009;114(1):26–31.; Peiretti M., Zanagnolo V., Aletti G.D. et al. Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: Surgical and oncological outcomes. Single institution experience. Gynecol Oncol 2010;119(2):259–64. DOI:10.1016/j. ygyno.2010.07.032.; Harter P., Muallem Z.M., Buhrmann C. et al. Impact of a structured quality management program on surgical outcome in primary advanced ovarian cancer. Gynecol Oncol 2011;121(3):615–9.; Wallace S., Kumar A., Mc Gree M. et al. Efforts at maximal cytoreduction improve survival in ovarian cancer patients, even when complete gross resection is not feasible. Gynecologic Oncology 2017;145(1):21– 6. DOI:10.1016/j.ygyno.2017.01.029.; Benedetti Panici P., Di Donato V., Fischetti M. et al. Predictors of postoperative morbidity after cytoreduction for advanced ovarian cancer: Analysis and management of complications in upperabdominal surgery. Gynecol Oncol 2015;137(3):406–11. DOI:10.1016/j.ygyno.2015.03.043.; Peiretti M., Bristow R.E., Zapardiel I. et al. Rectosigmoid resection at the time of primary cytoreduction for advanced ovarian cancer. A multi-center analysis of surgical and oncological outcomes. Gynecol Oncol 2012;126(2):220–3. DOI:10.1016/j.ygyno.2012.04.030.; Grimm C., Harter P., Alesina P.F. et al. The impact of type and number of bowel resections on anastomotic leakage risk in advanced ovarian cancer surgery. Gynecol Oncol 2017;146(3):498–503. DOI:10.1016/j. ygyno.2017.06.007.; Bartl T., Schwameis R., Stift A. et al. Predictive and prognostic implication of bowel resections during primary cytoreductive surgery in advanced epithelial ovarian cancer. Int J Gynecol Cancer 2018;28(9):1664–71. DOI:10.1097/IGC.0000000000001369.

  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20